0,1,2,3,4,5,6,7,8
A,,,,,,B,,
,45,,,,,,,
,,,,,,,90,Industry
,,Phase 1,Phase 2,Phase 3,Phase 4,,,
,40,,,,,,,
,,,,,,,80,Other
,,,,,,,,NIH
,35,,,,,,,
,,,,,,,70,
,30,,,,,,60,
"Hepatitis C Trials, %",25,,,,,"Hepatitis C Trials, %",50,
,20,,,,,,40,
,15,,,,,,30,
,,,,,,,20,
,10,,,,,,,
,,,,,,,10,
,"5 0
12",3,4,,,,,
,,,,,,,0,
